MENU
CVKD
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Cadrenal Therapeutics (CVKD) Ownership - Who owns Cadrenal Therapeutics?
Cadrenal Therapeutics Inc is developing tecarfarin, its drug candidate, for unmet needs in anticoagulation therapy... Show more
Profile
Industry
N/A
Address
822 A1A North
Phone
+1 904 300-0701
Employees
4
Web
https://www.cadrenal.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
26.28M
P/E Ratio
N/A
Total Cash
10.02M
Projected Growth
N/A
Total Debt
N/A
Revenue
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
5.09
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
CVKD
Capitalization
26.3M
P/E Ratio
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash
10M
Total Cash/Share
5.09
Total Debt
0
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
7.44M
P/B Ratio
4.30
Cash Flow
N/A
Earnings
-6.73
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
1.78K
Current Ratio
3.77
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-7.61M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-114.27
Shares Held By Institutions
1.09M
Shares Outstanding - Current
1.97M
Total Liabilities
2.68M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-7.764
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
822 A1A North
Phone
+1 904 300-0701
Employees
4
Web
https://www.cadrenal.com